Ledger.Open graph →
SEC Form D · filed April 2, 2018

GRADALIS, INC

Offering
$55.0M
Sold
$43.9M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
DALLAS, TX
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (23)

David M. Shanahan · Dallas, TXExec · DirectorRobert P. Landin · Dallas, TXDirectorScott C. Seaman · Dallas, TXDirectorKrishna Gade · Palo Alto, CAExec · DirectorAmit Paka · Palo Alto, CADirectorBilal Zuberi · Palo Alto, CADirectorErnest Bognar · Dallas, TXExecGladice Wallraven · Dallas, TXExecJoe Cunningham, M.D · Dallas, TXDirectorHarry Jacobson, M.D · Dallas, TXDirectorThomas Lyles · Dallas, TXDirectorJohn Nemunaitis, M.D · Dallas, TXExec · DirectorRenee Larson · Dallas, TXExecJames Lusk · Denver, COExec · DirectorRichard Ramlall · Denver, CODirectorPeter Holst · Denver, CODirectorErnest Bognar · Dallas, TXExecGladice Wallraven · Dallas, TXExecJoe Cunningham, M.D · Dallas, TXDirectorHarry Jacobson, M.D · Dallas, TXDirectorThomas Lyles · Dallas, TXDirectorJohn Nemunaitis, M.D · Dallas, TXExec · DirectorRenee Larson · Dallas, TXExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗